Neuralink’s Blindsight implant has received FDA breakthrough status, aiming to restore sight by stimulating the visual cortex ...
Radiopharmaceutical therapy (RPT) offers molecular-targeted treatment strategies and presents an ideal model for advancing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback